Navigation Links
Zimmer Awarded Premium Pricing for Trabecular Metal™ Modular Cup in Japan

WARSAW, Ind., Dec. 13, 2010 /PRNewswire/ -- Zimmer Holdings, Inc. (NYSE: ZMH; SIX: ZMH), a global leader in musculoskeletal care, announced today that the Trabecular Metal Modular Cup has received the distinction of being awarded the highest reimbursement premium percentage granted to-date for an orthopaedic product in Japan.  

The Japanese Central Social Insurance Medical Council, otherwise known as the Chuikyo, awarded Zimmer's Trabecular Metal Modular Cup with an unprecedented 20 percent reimbursement premium.  The decision was presented by the Chuikyo expert panel after a comprehensive review of both the material technology and clinical data.  It was the opinion of the expert panel that the extensive positive clinical data clearly demonstrated significant clinical advantages and effectiveness of Zimmer's proprietary Trabecular Metal Technology.  Based on the review, a new functional reimbursement category has been established in Japan for the Trabecular Metal Modular Cup and will be introduced on January 1, 2011.  

Trabecular Metal material is a highly porous biomaterial that resembles the structure, function, and physiology of trabecular bone.  No other porous metal material is supported by the amount of peer-reviewed, published clinical data of Trabecular Metal Technology and its history of proven success in orthopaedic applications.  This novel material is conducive to bone formation, enabling robust biologic fixation and a stiffness similar to cancellous bone.  The properties of  Trabecular Metal Technology allow for decreased stress shielding and the material has the potential to improve long-term implant fixation.

"We believe Trabecular Metal technology represents one of the most significant material advancements in orthopaedics, contributing both outstanding clinical advantages and cost effectiveness to implants," said Cheryl R. Blanchard, PhD, Zimmer's Senior Vice President and Chief Scientific Officer.  "Securing this reimbursement and its unprecedented premium level is a major achievement for Zimmer.  Japan is the world's second largest orthopaedics market after the United States and we are excited to provide the unique advantages of our Trabecular Metal technology to the patients of Japan."

About the Company

Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, dental implants, and related surgical products.  Zimmer has operations in more than 25 countries around the world and sells products in more than 100 countries.  Zimmer's 2009 sales were approximately $4.1 billion.  The Company is supported by the efforts of more than 8,000 employees worldwide.

Website Information

We routinely post important information for investors on our website,, in the "Investor Relations" section.  We intend to use this website as a means of disclosing material, non-public information and for complying with our disclosure obligations under Regulation FD.  Accordingly, investors should monitor the Investor Relations section of our website, in addition to following our press releases, SEC filings, public conference calls, presentations and webcasts.  The information contained on, or that may be accessed through, our website is not incorporated by reference into, and is not a part of, this document.

Zimmer Safe Harbor Statement

This press release contains forward-looking statements within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 based on current expectations, estimates, forecasts and projections about the orthopaedics industry, management's beliefs and assumptions made by management.  Forward-looking statements may be identified by the use of forward-looking terms such as "may," "will," "expects," "believes," "anticipates," "plans," "estimates," "projects," "assumes," "guides," "targets," "forecasts," and "seeks" or the negative of such terms or other variations on such terms or comparable terminology.  These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that could cause actual outcomes and results to differ materially.  For a list and description of such risks and uncertainties, see our periodic reports filed with the U.S. Securities and Exchange Commission.  We disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be set forth in our periodic reports.  Readers of this document are cautioned not to place undue reliance on these forward-looking statements, since, while we believe the assumptions on which the forward-looking statements are based are reasonable, there can be no assurance that these forward-looking statements will prove to be accurate.  This cautionary statement is applicable to all forward-looking statements contained in this document.

SOURCE Zimmer Holdings, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Comparative Study Shows Significant Bone In-growth and Advanced Clinical Outcomes Using Zimmers Trabecular Metal(TM) Technology
2. Zimmer Holdings Announces Live Audio Webcast and Conference Call of Third Quarter 2009 Results
3. Zimmer Reports Fourth Quarter and 2009 Financial Results
4. Zimmer Holdings, Inc. Agrees to Sell $1 Billion of Senior Notes
5. Zimmer Holdings Announces Live Audio Webcast and Conference Call of Fourth Quarter and Full-Year 2009 Results
6. Zimmer Holdings to Present at 21st Annual Piper Jaffray Health Care Conference
7. Ameritox(R) Appoints Jay B. Zimmerman as Chief Operating Officer
8. Zimmer Holdings to Present at Cowen & Company 30th Annual Health Care Conference
9. Zimmer Natural Knee Celebrates 25 Years of Excellence
10. Zimmer Holdings to Present at Bank of America Merrill Lynch 2010 Health Care Conference
11. Zimmer Holdings to Present at Bairds 2010 Growth Stock Conference
Post Your Comments:
(Date:11/26/2015)... , November 26, 2015 ... of the "2016 Future Horizons and ... Abuse Testing Market: Supplier Shares, Country Segment ... to their offering. --> ... "2016 Future Horizons and Growth Strategies ...
(Date:11/26/2015)... November 26, 2015 ... "Self Administration of High Viscosity Drugs" report ... has announced the addition of the "Self ... their offering. --> Research and Markets ... the "Self Administration of High Viscosity Drugs" ...
(Date:11/25/2015)... SYDNEY , Nov. 26, 2015  The total global ... nearly 7% over 2015-2016. Latin America ... Asia , (excluding Japan ), is ... continues to face increased healthcare expenditure. In 2013-2014, ... expenditure declined from 43.5% in 2008-2009 to 41.2% in 2013-2014. ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... 2015 , ... Dr. Thomas Dunlap and Dr. Patrick Coleman ... with Emergency Medicine at St., Joseph Health System’s Santa Rosa Memorial Hospital , ... in similar ways and require time-critical intervention to avoid large area heart damage and ...
(Date:11/27/2015)... ... , ... Indosoft Inc., developer and distributor of the world-class ... (Long Term Support) into its Q-Suite 5.10 product line. , Making the change ... version of Asterisk that will receive not only security fixes, but feature and ...
(Date:11/26/2015)... , ... November 26, 2015 , ... Inevitably when people ... customers choose to buy during the Black Friday and Cyber Monday massage ... need to search the Internet high and low to find the best massage chair ...
(Date:11/26/2015)... ... 26, 2015 , ... Somu Sivaramakrishnan announced today that he ... now offers travelers, value and care based Travel Services, including exclusive pricing on ... as, cabin upgrades and special amenities such as, shore excursions, discounted fares, travel ...
(Date:11/26/2015)... ... November 26, 2015 , ... Jobs in hospital medical laboratories and in the ... healthcare staffing agency Aureus Medical Group . These fields, as well ... those searching for healthcare jobs through the company’s website, , The ...
Breaking Medicine News(10 mins):